Viropro lands deal to acquire Alpha Biologics
US contract research and manufacturing services firm, Viropro, has signed a $21m (€15.3m) deal for the acquisition of Malaysia-based Alpha Biologics.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs